BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28801584)

  • 1. Differences of protein expression profiles, KRAS and BRAF mutation, and prognosis in right-sided colon, left-sided colon and rectal cancer.
    Gao XH; Yu GY; Gong HF; Liu LJ; Xu Y; Hao LQ; Liu P; Liu ZH; Bai CG; Zhang W
    Sci Rep; 2017 Aug; 7(1):7882. PubMed ID: 28801584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance].
    Xu KY; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):285-9. PubMed ID: 19434540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of survival between right-sided and left-sided colon cancer in different situations.
    Qiu MZ; Pan WT; Lin JZ; Wang ZX; Pan ZZ; Wang FH; Yang DJ; Xu RH
    Cancer Med; 2018 Apr; 7(4):1141-1150. PubMed ID: 29533001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles.
    Minoo P; Zlobec I; Peterson M; Terracciano L; Lugli A
    Int J Oncol; 2010 Sep; 37(3):707-18. PubMed ID: 20664940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage III & IV colon and rectal cancers share a similar genetic profile: a review of the Oregon Colorectal Cancer Registry.
    Gawlick U; Lu KC; Douthit MA; Diggs BS; Schuff KG; Herzig DO; Tsikitis VL
    Am J Surg; 2013 May; 205(5):608-12; discussion 612. PubMed ID: 23592171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sidedness is prognostic in locoregional colon cancer: an analysis of 9509 Australian patients.
    Brungs D; Aghmesheh M; de Souza P; Ng W; Chua W; Carolan M; Clingan P; Healey E; Rose J; Tubaro T; Ranson M
    BMC Cancer; 2017 Apr; 17(1):251. PubMed ID: 28390415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Yoon G; Park JY; Kim HJ; Choi GS; Kim JG; Kang BW; Kang MK; Seo AN
    Anticancer Res; 2019 Jun; 39(6):2845-2853. PubMed ID: 31177122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].
    Gao J; Sun ZW; Li YY; Shen L
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):579-83. PubMed ID: 23157823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of fibroblast growth factor receptor 2 expression in patients with residual rectal cancer after preoperative chemoradiotherapy: relationship with KRAS or BRAF mutations and MSI status.
    Yoon G; Lee H; Kim JH; Hur K; Seo AN
    Tumour Biol; 2016 Aug; 37(8):10209-18. PubMed ID: 26831663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of anatomical subsite on the incidence of microsatellite instability, and KRAS and BRAF mutation rates in patients with colon carcinoma.
    Benedix F; Meyer F; Kube R; Kropf S; Kuester D; Lippert H; Roessner A; Krüger S
    Pathol Res Pract; 2012 Oct; 208(10):592-7. PubMed ID: 22898351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy.
    Maus MK; Hanna DL; Stephens CL; Astrow SH; Yang D; Grimminger PP; Loupakis F; Hsiang JH; Zeger G; Wakatsuki T; Barzi A; Lenz HJ
    Pharmacogenomics J; 2015 Aug; 15(4):354-62. PubMed ID: 25532759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
    Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
    Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
    Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
    Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis.
    Frouws MA; Reimers MS; Swets M; Bastiaannet E; Prinse B; van Eijk R; Lemmens VE; van Herk-Sukel MP; van Wezel T; Kuppen PJ; Morreau H; van de Velde CJ; Liefers GJ
    PLoS One; 2017; 12(1):e0170775. PubMed ID: 28125730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal adenocarcinoma in Uganda: are right-sided and left-sided colon cancers two distinct disease entities?
    Wismayer R; Kiwanuka J; Wabinga H; Odida M
    World J Surg Oncol; 2023 Jul; 21(1):215. PubMed ID: 37480083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical influence of cancer stem cells on residual disease after preoperative chemoradiotherapy for rectal cancer.
    Yoon G; Kim SM; Kim HJ; Seo AN
    Tumour Biol; 2016 Mar; 37(3):3571-80. PubMed ID: 26456957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of oncogenesis in colon versus rectal cancer.
    Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
    J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.